Transdermal estrogen spray in therapy of postmenopausal syndrome

Abstract

Objective: To show possibilities of new application method of estrogen replacement therapy - mettered-dose transdermal spray. Design: Review article Results: Transdermal spray contains 1.53 mg estradiol in one dose.

It gives possibility of individual aproach in estradiol application 1, 2 or 3 doses daily. About 85% of patients showed the significant reduction of hot flushes.

Perfect safety profile is predicted especially in cardiovascular point.

Keywords

• mettered-dose transdermal spray
• hormone replacement therapy
• perimenopausal symptoms
• tromboembolic desease